The Europe pharmaceutical cold chain logistics market size was esteemed at $6.70 billion in 2022 and is estimated to reach $12.30 billion by 2032, exhibiting a CAGR of 6.5% from 2023 to 2032.
A cold chain is a fundamental part of pharma shipments and transits. It is often considered a temperature-controlled supply system used to store and transport perishable products, such as vaccines, biologics, and drugs. This chain must preserve a particular temperature range, often between 2°C and 8°C, to preserve the safety, potency, and efficacy of pharmaceutical products through the entire supply chain, from manufacturing and storage to transportation and distribution. Aside from directing processes, manufacturers, distributors, and healthcare providers benefit from technological innovations and developments to preserve the quality and integrity of pharmaceutical products and, consequently, ensure the safety of the consumers in need.
The integration of radiofrequency identification technology (RFID), AI, and blockchain technology in pharmaceutical cold-chain logistics is expected to revolutionize the cold-chain logistics industry, making it more efficient and secure. RFID system for cold chain applications consists of a reader, a tag, and a sensor that communicate with one another via radio transmission. If they have the right sensor and enough power, RFID tags can store a finite number of temperature measurements in addition to an electronic product code (EPC) for logistics management purposes.
In addition, RFID technologies improve the performance of perishable supply chains through the device to track the geographical position of individual packages, pallets, shipping containers, or trucks, which can be stationary or in movement during distribution. These technologies are used to identify items through a unique EPC or other barcode and to store real-time environmental data (including temperature), which is later transmitted, allowing corrective actions to be taken before products are irrevocably damaged. The technology provides manufacturers the transparency in tracing and protecting throughout the product supply chain.
Rise in several refrigerated warehouses and expansion of the pharmaceutical sector, along with the government policies and initiatives to promote cold chain logistics is expected to drive the growth of the pharmaceutical cold chain logistics market. In addition, the constant development of machines and medicines due to the rising number of approvals for pharmaceutical products in Europe fuels the growth of the aftermarket shock absorbers market. On the contrary, the rise in the number of products and services, from vaccines to cell and gene therapies, requires cold chain handling and refrigerated warehouses are projected to offer lucrative opportunities for the expansion of the market during the forecast period.
However, there is a concern about the high cost required for maintaining cold chain logistics, such as refrigerated storage facilities and transportation systems that poses a considerable challenge to the growth of the market. This cost can act as a barrier for smaller pharmaceutical companies or those operating in developing regions. Further, temperature excursions or disruptions in the cold chain may result in the loss of valuable pharmaceutical products. This risk is especially significant for temperature-sensitive medications, vaccines, and biologics, leading to financial losses and potential reputational damage for pharmaceutical companies. This is expected to hamper the growth of Europe's pharmaceutical cold chain logistics market.
The European pharmaceutical cold chain logistics market is segmented into product, temperature type, mode of transportation, and region.
A cold chain is a fundamental part of pharma shipments and transits. It is often considered a temperature-controlled supply system used to store and transport perishable products, such as vaccines, biologics, and drugs. This chain must preserve a particular temperature range, often between 2°C and 8°C, to preserve the safety, potency, and efficacy of pharmaceutical products through the entire supply chain, from manufacturing and storage to transportation and distribution. Aside from directing processes, manufacturers, distributors, and healthcare providers benefit from technological innovations and developments to preserve the quality and integrity of pharmaceutical products and, consequently, ensure the safety of the consumers in need.
The integration of radiofrequency identification technology (RFID), AI, and blockchain technology in pharmaceutical cold-chain logistics is expected to revolutionize the cold-chain logistics industry, making it more efficient and secure. RFID system for cold chain applications consists of a reader, a tag, and a sensor that communicate with one another via radio transmission. If they have the right sensor and enough power, RFID tags can store a finite number of temperature measurements in addition to an electronic product code (EPC) for logistics management purposes.
In addition, RFID technologies improve the performance of perishable supply chains through the device to track the geographical position of individual packages, pallets, shipping containers, or trucks, which can be stationary or in movement during distribution. These technologies are used to identify items through a unique EPC or other barcode and to store real-time environmental data (including temperature), which is later transmitted, allowing corrective actions to be taken before products are irrevocably damaged. The technology provides manufacturers the transparency in tracing and protecting throughout the product supply chain.
Rise in several refrigerated warehouses and expansion of the pharmaceutical sector, along with the government policies and initiatives to promote cold chain logistics is expected to drive the growth of the pharmaceutical cold chain logistics market. In addition, the constant development of machines and medicines due to the rising number of approvals for pharmaceutical products in Europe fuels the growth of the aftermarket shock absorbers market. On the contrary, the rise in the number of products and services, from vaccines to cell and gene therapies, requires cold chain handling and refrigerated warehouses are projected to offer lucrative opportunities for the expansion of the market during the forecast period.
However, there is a concern about the high cost required for maintaining cold chain logistics, such as refrigerated storage facilities and transportation systems that poses a considerable challenge to the growth of the market. This cost can act as a barrier for smaller pharmaceutical companies or those operating in developing regions. Further, temperature excursions or disruptions in the cold chain may result in the loss of valuable pharmaceutical products. This risk is especially significant for temperature-sensitive medications, vaccines, and biologics, leading to financial losses and potential reputational damage for pharmaceutical companies. This is expected to hamper the growth of Europe's pharmaceutical cold chain logistics market.
The European pharmaceutical cold chain logistics market is segmented into product, temperature type, mode of transportation, and region.
- Product
- Vaccines,
- Biologics,
- Specialty Medications
- Others.
- Type,
- Chilled
- Frozen
- Room Temperature
- Mode Of Transportation
- Railways
- Airways
- Roadways
- Waterways.
- Country
- France
- Germany
- Italy
- Spain
- UK
- Switzerland
- Ireland
- The Rest of Europe.
- Key players covered in the report
- A.P. Moller-Maersk
- DB Schenker
- DHL Group
- DSV
- Geodis
- H. Essers
- Kuehne + Nagel
- Movianto
- Sovereign
- VTS Transport & Logistics.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT
CHAPTER 5: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE
CHAPTER 6: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION
CHAPTER 7: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY COUNTRY
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
Key Market Players in the Europe Pharmaceutical Cold Chain Logistics Market include:- A.P. Moller–Maersk
- DB Schenker
- DHL Group
- DSV
- Geodis
- H. Essers
- Kuehne + Nagel
- Movianto
- Sovereign
- VTS Transport & Logistics
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
